# A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor

> **NCT05021991** · PHASE2 · COMPLETED · sponsor: **Praxis Precision Medicines** · enrollment: 133 (actual)

## Conditions studied

- Essential Tremor

## Interventions

- **DRUG:** 100 mg PRAX-944
- **DRUG:** 60 mg PRAX-944
- **DRUG:** Placebo
- **DRUG:** Flexibly dosed 20 mg to 100 mg PRAX-944

## Key facts

- **NCT ID:** NCT05021991
- **Lead sponsor:** Praxis Precision Medicines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-14
- **Primary completion:** 2023-02-09
- **Final completion:** 2024-02-29
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05021991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05021991, "A Clinical Trial of 2 Doses of PRAX-944 in Participants With Essential Tremor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05021991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*